Reported results
- Net sales were $228.9 million, an increase of 13.1% over the prior year period.
- Organic net sales growth was 11.5%.
- Net earnings were $20.9 million compared to $14.3 million in the prior year period.
- Adjusted EBITDA was $42.9 million, an increase of 44.9% compared to $30 million in the prior year period.
- Adjusted EBITDA margin was 18.7%.
- Net debt was $199.8 million and the Net leverage ratio was 1.2x as of quarter-end.
Guidance
- Full-year 2026 Net sales guidance range of $953-973 million.
- Full-year 2026 Estimated Standalone Adjusted EBITDA guidance range of $168-178 million.
- Full-year 2026 Change in Organic net sales guidance of ~7%.
- Full-year 2026 Non-cash share-based compensation expense guidance of $12 million to $13 million.
- Full-year 2026 Depreciation and Amortization guidance of $26 million to $28 million.
- Full-year 2026 Interest expense, net guidance of $8 million to $9 million.
- Full-year 2026 Diluted Weighted Average Shares Outstanding guidance of 45 million to 46 million.
Notes
In the third quarter of 2026, the Company revised its definition of acquisition related adjustments to include transaction costs related to both potential and completed transactions; prior period amounts have been recast to conform to the revised definition.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-17 (8-K, Item 2.02). Read the original filing on sec.gov.
